Centre for Personalised Medicine; Clinical Decision Making and Patient Safety (Q4296117): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Attach the beneficiary based on the string) |
(Changed an Item: Change because item Q4361294 was merged with Q4356452) |
||
| Property / beneficiary | Property / beneficiary | ||
Revision as of 20:40, 24 June 2022
Project Q4296117 in Ireland, United Kingdom
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Centre for Personalised Medicine; Clinical Decision Making and Patient Safety |
Project Q4296117 in Ireland, United Kingdom |
Statements
7,415,032.63 Euro
0 references
9,424,926.67 Euro
0 references
78.67 percent
0 references
1 April 2017
0 references
31 December 2021
0 references
Ulster University
0 references
54°57'36.07"N, 7°44'3.62"W
0 references
54°30'47.88"N, 6°2'44.16"W
0 references
57°28'11.14"N, 4°13'47.21"W
0 references
54°57'3.38"N, 7°13'46.96"W
0 references
54°57'1.04"N, 8°21'26.50"W
0 references
54°27'3.13"N, 6°25'10.70"W
0 references
53°16'33.74"N, 9°3'34.52"W
0 references
57°28'22.33"N, 4°11'19.57"W
0 references
54°57'4.14"N, 7°43'20.21"W
0 references
54°58'44.36"N, 7°17'1.36"W
0 references
54°57'54.07"N, 7°43'4.51"W
0 references
Personalised medicine is a research-based medical approach to guide clinical decisions to ensure a patient receives the right treatment at the right time is now recognised as a key priority internationally. While the promises of personalised medicine are only now beginning to be realised in certain areas of cancer medicine in particular, other disease areas have been slow to adopt or benefit from this approach, partly because of a lack of appropriate clinical engagement. This project will create the oft cited highly sought after ethos and environment needed if personalised medicine is to be adapted in the partner hospitals and in five disease areas that have not yet engaged the personalised medicine discipline. This aim is therefore to establish a Centre for Personalised Medicine; Clinical Decision Making and Patient Safety (CPM) which will dramatically enhance the regional capability while serving as a magnet for regional and FDI industry to create innovative products and new optimised care pathway tools in priority disease areas for patients and commercial benefit. The five Research Clusters (RCs) will utilize the methods and technologies from personalised medicine and apply them to heart disease, emergency surgery, acute kidney injury, unscheduled care in diabetes and diagnostic accuracy in dementia. These are areas associated with significant clinical need and commercial potential and will benefit significantly from the interdisciplinary academic and commercial cross-border expertise and collaboration. The major strength of the proposal resides in the expertise of the assembled highly complementary multidisciplinary team of clinicians, academic researchers and enterprises. The immediate objectives of this proposal are to: - Improve the triage of patients with chest pain to allow more appropriate and rapid emergency referral for PCI. - Identify determinants of outcomes in emergency surgery to improve care pathways and reduce morbidity and mortality. - Earlier recognition of AKI to reduce mortality, morbidity and hospital stay. - Improve the self-management of diabetes to reduce unscheduled care episodes and hospital admissions. - Develop tools which will allow earlier diagnosis of dementia and therefore earlier clinical intervention and support. (English)
0 references